TrialGeneral thoracic and cardiovascular surgery2016

Neoadjuvant chemotherapy of triplet regimens of docetaxel/cisplatin/5-FU (DCF NAC) may improve patient prognosis of cStage II/III esophageal squamous cell carcinoma-propensity score analysis.

Keishi Yamashita et al.PubMed ↗Publisher ↗

No numbers read from the abstract.